The Library and the PDLC is pleased to announce the return of The Perspectives on Science Careers seminar for 2017.
Interested in entrepreneurship and don’t know where to start or seeking the best way to transition from bench science to healthcare venture capital and the like?
The Perspectives on Science Careers seminar series will feature “Venture Capital 101: From bench science to healthcare venture” by The Deerfield Institute, in the upcoming seminar on Tuesday, February 28th at 2:00pm, in the Szybalski Room at the Library.
Please join us for the panel discussion and bring your questions for an extensive Q&A to follow. The panel discussion will be followed by tea/coffee networking session in the library.
We hope to see you there!
When: Tuesday, February 28, 2017
Time: 2:00 pm – 3:00 pm
Where: Szybalski Reading Room, CSHL Library
Speakers: Jonathan Leff, William Slattery, Robert Jackson and Karen Heidelberger
Mr. Leff is a Partner on the Private Transactions team and Chairman of the Deerfield Institute. He joined Deerfield in 2013, and focuses on venture capital and structured investments in biotechnology and pharmaceuticals. Prior to joining Deerfield, for more than sixteen years, Mr. Leff was with Warburg Pincus, where he led the firm’s investment efforts in biotechnology and pharmaceuticals. Mr. Leff has also been active in public policy discussions related to healthcare and medical innovation. He serves on the Emerging Companies Section Board of the Biotechnology Industry Organization and is a member of several not-for-profit Boards, including the Spinal Muscular Atrophy Foundation, Friends of Cancer Research, and the Columbia University Medical Center Board of Advisors. In addition, he previously served as a member of the Executive Committee of the Board of the National Venture Capital Association (NVCA), and previously led NVCA’s life sciences industry efforts as Chair of NVCA’s Medical Innovation and Competitiveness Coalition (NVCA-MedIC). Mr. Leff received his A.B. from Harvard University, and earned his M.B.A. from The Stanford Graduate School of Business.
Mr. Slattery is a Partner on the Private Transactions team at Deerfield, which he joined in 2000. He began his professional career studying immune system complications associated with End Stage Renal Disease. Prior to joining Deerfield, Mr. Slattery was a senior healthcare analyst between 1990 and 2000 at Amerindo Investment Advisors overseeing biotechnology investments. He has held various positions in research including those at National Medical Enterprises, Johnson & Johnson, and HMSS. Mr. Slattery has a degree in Biology from State University of New York at Albany and completed coursework in Immunology at the Graduate School-New Brunswick, Rutgers University.
Robert Jackson, M.D.
As a Partner on the Biotech team at Deerfield since 2001 and the Chief Science Officer since 2014, Dr. Jackson provides extensive research and analysis on individual companies operating in the healthcare industry. Prior to joining Deerfield, Dr. Jackson was a healthcare analyst at Janus Capital from 1999 to 2001. Previously, he founded and managed a group ophthalmology practice. Dr. Jackson earned his undergraduate degree at Rollins College and his medical degree at West Virginia University. He earned an M.B.A. with distinction from the Wharton School at the University of Pennsylvania, was a Cleveland Fellow from Case Western Reserve University, spent a year at the Royal Melbourne Hospital in Australia, completed his ophthalmology residency at Case Western Reserve University and was Chief Resident in his final year. Dr. Jackson is also a CFA charter holder.
As Chief Partnership and Communications Officer at Deerfield, Ms. Heidelberger is responsible for relationships with investors, partner companies, and other interested parties. Prior to this role, Ms. Heidelberger was a Trader at Deerfield for over a decade. In this capacity, she was responsible for trading in public securities on behalf of the Funds and developing and communicating market information to the firm. Prior to joining Deerfield in 2002, Ms. Heidelberger was a Vice President in the Sales and Trading division of Merrill Lynch. Also at Merrill, she served as a Conflicts Coordinator in the Mergers and Acquisitions department. In this role she was responsible for ensuring that Merrill Lynch was clear of legal and business conflicts of interest before the firm was able to accept an assignment. Ms. Heidelberger is on the board of the Cornell Institute for Healthy Futures since 2016. She graduated from the Cornell University, School of Hotel Administration and earned her M.B.A. from Harvard Business School.
Tuesday 2/7 was the final session of the Inaugural CSHL/BOCES Science Journal Club. The Science Journal Club brought together high school students, their science teachers and Librarians and CSHL PI's, post docs and members of the Library to learn how to find, read, analyze, present and discuss scientific journal articles.
Click on the above photo for more images taken at the CSHL/BOCES Journal Club.
Continuing its unique meeting series blending history and current research, Cold Spring Harbor Laboratory hosted HIV/AIDS Research: Its History & Future, from October 13 to 16, 2016. Like other meetings in the series, this event brought together pioneers in the field of human retroviruses for a dynamic discussion about how the past has shaped the present – and how to get to the next phase of treating HIV/AIDS. CSHL holds a significant place in the history of retrovirus research, being the site of some of the earliest announcements of HIV’s existence in 1983. It was an appropriate place, then, to bring together the most important HIV/AIDS researchers in the disease’s history, including Dr. Robert Gallo, one of the meeting’s organizers. A complete record of the meeting – this includes talks, slides, photos, and bios – is now available online.
A new demand-driven ebook platform is available from the CSHL Library! ProQuest EBook Central provides CSHL researchers and staff an easy way to discover and read a vast collection of scientific and technical books from leading publishers. You are able to easy discover books of interest and can read the full text of any book for 5 minutes. If you decide that the book is worthwhile, simple request the book directly on the website, and your reqest will be processed by a CSHL Librarian.
For details on using the EBook Central, we have a Ebook Central LibGuide.
A major undertaking by the CSHL Library & Archives, the "The Human Genome Project: An Annotated & Interactive Scholarly Guide to the Project in the United States" is now available as an online guide and a downloadable E-Book. The editor is Kevin Davies.
Baker et al J Cell Sci 2016
Generation and characterization of an inducible knockdown mouse model for SCRIB
Crow et al Genom Biol 2016
Comparative network analysis shows higher functional connectivity, semantic similarity, and convergent co-expression of UMI-based aggregates
Fagegaltier et al Genes & Dev 2016
The effects of depleting piRNA pathway components.
He et al Neuron 2016
Intersectional Targeting of the SST/CR Subpopulation
Pedmale et al Cell 2016
Graphical representation of the findings presented in the paper
Understanding your rights as an author and copyright this important for all scientists from graduate students to PI's.
DO YOU HAVE AN ORCID ID YET?
The Open Researcher and Contributor ID (ORCID) is a 16-digit number unique to each individual and helps to eliminate author name ambiguity and improve discoverability of your research and scholarly works. ORCID is well supported by all the major publishers, as well as a number of funding agencies and institutions.
The CSHL Library supports ORCID’s mission and is an ORCID institutional member enabling the creation of ORCID records on behalf of our authors . You can contact us or we can visit you to assist in the process. If you wish to create an ORCID on your own our libguide explains the process in more depth.
Please contact Mila Pollock or Matt Covey if you have any questions or need our help to register for ORCID.
Altmetric "watches social media sites, newspapers, government policy documents and other sources for mentions of scholarly articles. We bring all the attention together to compile article level metrics"
Altmetric allows researchers to see where publications are being talked about and by whom.